MedTrace Logo

Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes

NCT01341067 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 30

Last updated 2014-05-02

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to examine the effect CGM (continuous glucose monitoring) has on subjects with type 2 diabetes. It is anticipated that patients using the device will obtain tighter control of their blood sugars resulting in measureable health benefits and improved confidence in their ability to manage their diabetes.

Conditions

Sponsors & Collaborators

  • Rocky Mountain Diabetes and Osteoporosis Center

    lead INDUSTRY

Principal Investigators

  • David R. Liljenquist, MD · Rocky Mountain Diabetes and Osteoporosis Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2011-12-31
Completion
2011-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01341067 on ClinicalTrials.gov